Divi's Laboratories’ Q2FY25 consolidated net profit rises 47% to Rs 510 crore

11 Nov 2024 Evaluate

Divi's Laboratories has reported results for second quarter ended September 30, 2024 (Q2FY25). 

The company has reported 51.46% rise in its net profit at Rs 518 crore for the quarter ended September 30, 2024 as compared to Rs 342 crore for the same quarter in the previous year. Total income of the company increased by 23.25% at Rs 2,407 crore for Q2FY25 as compared to Rs 1,953 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 46.55% rise in net profit at Rs 510 crore for Q2FY25 as compared to Rs 348 crore for the same quarter in the previous year. Total income of the company increased by 22.51% at Rs 2,444 crore for Q2FY25 as compared to Rs 1,995 crore for the corresponding quarter previous year.


Divis Lab Share Price

5999.40 23.70 (0.40%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.